CONNECTICUT INDUSTRY

Connecticut Healthcare News

Teva Buys BioXcel Drug Assets for $57.5 Million

Teva Buys BioXcel Drug Assets for $57.5 Million

BioXcel Therapeutics completes the sale of its main drug assets as it moves toward winding down its business.

Live Poll

Do you trust large companies to treat workers fairly when they go bankrupt?


Recent news